Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114621985B reveals enzymatic synthesis breakthrough. Delivers high purity and supply chain reliability for global pharmaceutical intermediate procurement strategies.
Novel enzymatic Mitsunobu route for high-purity chiral intermediates. Reduces cost and improves yield for pharmaceutical manufacturing supply chains globally.
Patent CN101535467B discloses a novel biocatalytic route for chiral hydroxy acids using Fusarium proliferatum ECU2002, offering high optical purity and scalable manufacturing solutions.
Patent CN106119224B reveals high-efficiency esterase for chiral synthesis. Offers mild conditions and supply chain stability for pharma intermediates.
Patent CN102994470A details a novel Aus EH-B enzyme for high-purity chiral epichlorohydrin. Discover cost-effective biocatalytic solutions for pharmaceutical intermediates.
Patent CN104263802B enables high-purity S-1-tetrahydronaphthalene amines via dynamic kinetic resolution, ensuring supply chain reliability.
Patent CN104152527A details DKR method for R-2-naphthylethylamine. High purity, cost-effective Raney Nickel catalyst. Reliable supply chain for pharmaceutical intermediates.
Patent CN109180496B details a novel lipase-catalyzed resolution and Mitsunobu reaction for Cinacalcet. Achieve high purity without hazardous reducing agents.
Patent CN101573330A reveals a novel stereo-selective route for trans-[18F]-FACBC precursors, offering significant cost reduction in PET tracer manufacturing and supply chain reliability.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN110835639B reveals a high-efficiency enzymatic route for producing chiral tetrahydroisoquinoline intermediates with superior stereoselectivity and scalable manufacturing potential.
Patent CN1425019A discloses a novel enzymatic route for vitamin D precursors, offering cost reduction in pharmaceutical intermediates manufacturing through scalable crystallization.
Patent CN111875577B details a one-pot synthesis of high-purity R-propylene carbonate using recyclable S-salen Co(II), offering significant cost and waste reduction for API manufacturers.
Discover the environmentally friendly synthesis of chiral 2,3-alkenols using lipase catalysis. A breakthrough in pharmaceutical intermediate manufacturing offering high purity and cost efficiency.
Patent CN1240646C details a novel enzymatic process for high-purity (-)-menthol. Discover cost-effective synthetic routes and supply chain advantages for global procurement.
Patent CN1761742A reveals recombinant lactonase technology for efficient D-pantolactone synthesis, offering cost reduction and supply stability for vitamin B5 manufacturers.
Patent CN105420285B reveals a scalable enzymatic method for producing optically active heptadecene compounds, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Discover the advanced Lewis acid-mediated reduction and enzymatic resolution process for high-purity cis-4-O-protected-2-cyclopentenol derivatives used in immunosuppressants.